Merck (MRK) announced the Japanese Ministry of Health, Labor and Welfare has approved new indications for KEYTRUDA or pembrolizumab, ...
Merck said on Wednesday its therapy did not meet the main goal of a late-stage trial evaluating it in patients with a type of ...
We recently published a list of the 13 Most Undervalued Blue Chip Stocks To Buy According To Analysts. In this article, we ...
An FDA advisory panel on Bristol Myers Squibb Opdivo and Merck Keytruda will examine if PD-L1 tumor expression should limit ...
Merchants Capital Secures more than $59M for upgrade of Gaithersburg multifamily housing development
Listen to this article Financial services provider Merchants Capital Tuesday announced more than $59 million in financing for ...
Shares of Merck & Co. Inc. MRK dropped 0.58% to $114.96 Tuesday, on what proved to be an all-around positive trading session ...
Merck Animal Health, a division of Merck & Co., Inc. (MRK), Tuesday announced the expansion of Nobivac NXT vaccine platform with the ...
NYSE:MRK) Merck Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus ...
In the last year, many Merck & Co., Inc. ( NYSE:MRK ) insiders sold a substantial stake in the company which may ...
Shares of Merck & Co. Inc. MRK shed 1.31% to $115.63 Monday, on what proved to be an all-around great trading session for the ...
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...
The Committee for Medicinal Products for Human Use recommends marketing approval for Merck's Keytruda for treating two types ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback